broker's call

Broker's Calls

Analysts stay 'neutral' on Raffles Medical Group as it normalises from its Covid-19 high

Analysts are mostly 'neutral' on Raffles Medical Group, as they keep a 'wait and see' approach following its normalising FY2023.

Broker's Calls

Analysts remain optimistic on Singtel following 3QFY2024 results

Singtel's 3QFY2023 was a miss with analysts, but 'buy' calls all around maintained.

Broker's Calls

Maybank keeps Frencken as top Singapore tech pick, ups target price on strong recovery ahead

Maybank likes Frencken Group as a beneficiary of the semi-con recovery.
'Accumulate' on CLAS as further upside from occupancy growth expected - THE EDGE SINGAPORE

Broker's Calls

'Accumulate' on CLAS as further upside from occupancy growth expected

PhillipCapital keeps CLAS as its top hospitality pick, but downgrades its call to 'accumulate'
Despite drop in FY2023 DPU, analysts remain upbeat on CLAR's outlook - THE EDGE SINGAPORE

Broker's Calls

Despite drop in FY2023 DPU, analysts remain upbeat on CLAR's outlook

Higher interest rates may have affected CLAR's FY2023, but analysts see more upside in the longer run.

Broker's Calls

DBS expects Singtel to post annual earnings growth of 10% in FY2024 results

DBS expects a 10% y-o-y increase in Singtel's earnings for 2HFY2024.

Broker's Calls

HRnetGroup to see growth led by economic recovery in Singapore and China: RHB

Strong financial and being a beneficiary of the improving economy keeps HRnetGroup at 'buy': RHB

Broker's Calls

CDL top pick for Singapore residential sector; robust pipeline of launches ahead: DBS

DBS sees CDL as a proxy to Singapore's residential property market and notices trends that could boost CDL's share price up.

Broker's Calls

Singtel remains RHB's top Singapore telco pick; Telco sector to see some upside in 2024

RHB sees some upside for the local telco sector this year. It has zoomed in on Singtel as its top sector pick.

Broker's Calls

OCBC Investment initiates 'buy' on PLife REIT with fair value of $4.27

OCBC Investment initiates a 'buy' on PLife REIT, as the counter is seen as a "stable and defensive income stream".
×